2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan



Tokyo Metropolitan Institute of Medical Science
field of research
Tokyo Metropolitan Institute of Medical Science was established in April 2011 by the merge of three Tokyo metropolitan government-operated institutes, namely, Tokyo Metropolitan Institute for Neuroscience, Tokyo Institute of Psychiatry, and the Tokyo Metropolitan Institute of Medical Science. The ultimate goal of the institute is to improve the health and welfare of the citizens of the Tokyo city as well as those of our country through original discovery on the pathology and molecular basis of diseases and development of novel strategies for prediction, prevention, diagnosis and therapy of various diseases including mental disorders.
2014.OCT.4 Releasing dentate nucleus cells from Purkinje cell inhibition generates output from the cerebrocerebellum
2014.JULY.3 Disease modifying effect of adiponectin in model of α-synucleinopathies.
2014.JUNE.6 The adipocyte-inducible secreted phospholipases PLA2G5 and PLA2G2E play distinct roles in obesity
2014.MAY.21 mTORC2 in the center of cancer metabolic reprogramming
2014.MAY.1 Ubiquitin is phosphorylated by PINK1 to activate parkin
2014.APR.5 Distinct pathways leading to TDP-43-induced cellular dysfunctions
2014.MAR.6 Quantitative live-cell imaging reveals spatio-temporal dynamics and cytoplasmic assembly of the 26S proteasome.
2013.DEC.26  Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus